Literature DB >> 32259400

Going remote: Maintaining normalcy in our pathology laboratories during the COVID-19 pandemic.

Emilio Madrigal1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; remote; remote learning; social distancing; video conference; virtual; virtual conference; virtual tumor board

Mesh:

Year:  2020        PMID: 32259400      PMCID: PMC7262355          DOI: 10.1002/cncy.22276

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


× No keyword cloud information.
Less than 2 months after the first case of coronavirus disease (COVID‐19) was reported in the United States, its incidence has started to grow exponentially. Without an available vaccine to slow the spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), many pathology departments are following the guidance of public health professionals, who recommend the practice of social distancing by avoiding common spaces and generally limiting human interactions. Nationally, at many academic medical centers, this has led to the deferrals of elective procedures and the consolidation of clinical services, thereby considerably reducing the number of attendings, fellows, and residents physically present on campus. To minimize disruptions to the practice of academic pathology, one can leverage modern information and communication technologies to create virtual connections. Daily consensus conferences in our pathology laboratories, including cytology, are valuable, educational, and necessary, but sitting around a multihead microscope with several colleagues neutralizes the goal of social distancing. Using web‐based video conferencing tools with an end‐to‐end encrypted connection allows pathologists to share diagnostically challenging cases remotely. Once the online conference is initiated, invited participants can join the session. One or more participants can share their computer screen, enabling them to broadcast the feed of a microscope‐mounted camera as they drive a slide in real time (Fig. 1). Other windows, such as the electronic health record or laboratory information system, can be shared. Participants communicate via chat or voice (computer microphone or telephone call). A collaboration interface component facilitates on‐screen annotations, which are ideal for highlighting diagnostic findings. Similarly, other clinical activities such as multidisciplinary tumor boards can benefit from the same setup, in which clinicians, diagnosticians, and surgeons can broadcast patients' charts and diagnostic imaging while openly discussing management plans.
Figure 1

Remote cytology consensus conference. Screen capture showing 23 participants assessing a fine needle aspiration biopsy positive for lymphoma. The meeting host was broadcasting a real‐time feed of their microscope‐mounted camera.

Remote cytology consensus conference. Screen capture showing 23 participants assessing a fine needle aspiration biopsy positive for lymphoma. The meeting host was broadcasting a real‐time feed of their microscope‐mounted camera. One of the pillars of academic pathology is the education of residents and fellows. In emergencies wherein workforce preservation is of the utmost importance, residents and fellows may be asked to stay home unless covering a critical service. To mitigate the loss of teaching “scope” sessions, pathologists continue to review cases with residents and fellows following an approach similar to that of consensus conferences. Another essential educational effort is a daily “unknown” session. These sessions present a unique challenge when most residents are remote, considering they need to review the glass slides before the meeting. Using whole‐slide imaging scanners capable of producing multilayer captures, which are particularly important for cytology specimens, enables us to distribute digitized slides for remote viewing through our web‐based educational platform. At the Massachusetts General Hospital, the resiliency of our anatomic, clinical, and cytology laboratories has been challenged, but working together to devise solutions under unprecedented circumstances has been a fruitful experience. Through ingenuity and adaptability, patient care continues to benefit from professional discussions, and educational sessions have remained intact. The overall sentiment after switching to a predominantly remote environment has been overwhelmingly positive, and this presents a novel opportunity to explore additional digital workflows.

Funding Support

No specific funding was disclosed.

Conflict of Interest Disclosures

The author made no disclosures.
  6 in total

Review 1.  Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples.

Authors:  Alton B Farris; Juan Vizcarra; Mohamed Amgad; Lee A D Cooper; David Gutman; Julien Hogan
Journal:  Histopathology       Date:  2021-03-08       Impact factor: 5.087

2.  International perspectives: Impact of the COVID-19 pandemic on cytology.

Authors:  Esther Diana Rossi; Liron Pantanowitz
Journal:  Cancer Cytopathol       Date:  2020-04-07       Impact factor: 5.284

3.  Considerations for remote learning in pathology during COVID-19 social distancing.

Authors:  Regina Kwon; M Lisa Zhang; Christopher J VandenBussche
Journal:  Cancer Cytopathol       Date:  2020-06-04       Impact factor: 5.284

4.  Impact of COVID-19 pandemic on functioning of cytopathology laboratory: Experience and perspective from an academic centre in New York.

Authors:  Renu K Virk; Teresa Wood; Patricia G Tiscornia-Wasserman
Journal:  Cytopathology       Date:  2021-01-19       Impact factor: 1.286

Review 5.  Towards a "Net" generation of Pathologists: the pathCast online remote learning platform.

Authors:  Luca Cima; Rifat Mannan; Emilio Madrigal; Mattia Barbareschi
Journal:  Pathologica       Date:  2020-10-20

6.  Innovations: Innovating together while social distancing.

Authors:  Xiaoyin Sara Jiang; Emilio Madrigal
Journal:  Cancer Cytopathol       Date:  2020-10-15       Impact factor: 4.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.